CuVue Orphalan

EUIPO EUIPO 2021 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark CuVue Orphalan was filed as Figurative mark on 11/02/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/03/2022. The current status of the mark is "Trademark registered".

Logodesign (Wiener Klassifikation)

#Surfaces or backgrounds covered with circles or ellipses #Moiré surfaces or backgrounds, marble, degrading surfaces, wooden-like surfaces, rainbow colours surfaces #Several ellipses, juxtaposed, tangential or intersecting

Trademark Details Last update: February 8, 2024

Trademark form Figurative mark
File reference 018591187
Application date November 2, 2021
Publication date November 24, 2021
Entry date March 3, 2022
Expiration date November 2, 2031

Trademark owner

226 boulevard Voltaire
75011 PARIS
FR

Trademark representatives

51 rue de Miromesnil 75008 PARIS FR

goods and services

5 Pharmaceutical preparations; Pharmaceutical products; Chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; Medicinal substances; Medicinal preparations; chemical preparations for medical or pharmaceutical use for the treatment of Wilson's disease; pharmaceutical products and medicines for the treatment of Wilson's disease; pharmaceutical preparations for the diagnosis of Wilson disease; pharmaceutical and chemical preparations for copper level measurement; chemical reagents for medical purposes; chemical reagents for diagnostic purposes in patients with Wilson's disease; pre-filled syringes for medical purposes; serums for diagnostic purposes; biological preparations for medical purposes for the measurement of copper in patients with Wilson's disease; chemical preparations for medical purposes for the measurement of copper in patients with Wilson's disease; clinical diagnostic reagents; diagnostic preparations for medical purposes for treatment of Wilson's disease; medical diagnostic reagents and assays for testing of body fluids to diagnose the level of copper
44 Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for diagnostic of copper levels in patients with Wilson's disease; medical screening; health care for patients with Wilson's disease; health assessment services care for patients with Wilson's disease; home-visit nursing care; blood testing services provided by medical laboratories for patients with Wilson's disease; medical clinic services and medical analysis services provided by medical laboratories for diagnostic purposes for patients with Wilson's disease; medical analysis services provided by medical laboratories for diagnostic purposes to measure copper levels in patients with Wilson's disease; medical diagnostic testing, monitoring and reporting services for patients with Wilson's disease; medical testing for diagnostic or treatment purposes in the field of Wilson's disease

ID: 11018591187